药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alphacetylmethadol
Eptinezumab
Estradiol acetate may increase the thrombogenic activities of Eptinezumab.
Alphacetylmethadol
Erenumab
Estradiol acetate may increase the thrombogenic activities of Erenumab.
Alphacetylmethadol
Burosumab
Estradiol acetate may increase the thrombogenic activities of Burosumab.
Alphacetylmethadol
Tildrakizumab
Estradiol acetate may increase the thrombogenic activities of Tildrakizumab.
Alphacetylmethadol
Besilesomab
Estradiol acetate may increase the thrombogenic activities of Besilesomab.
Alphacetylmethadol
Sulesomab
Estradiol acetate may increase the thrombogenic activities of Sulesomab.
Alphacetylmethadol
Emicizumab
Estradiol acetate may increase the thrombogenic activities of Emicizumab.
Alphacetylmethadol
Human cytomegalovirus immune globulin
Estradiol acetate may increase the thrombogenic activities of Human cytomegalovirus immune globulin.
Alphacetylmethadol
Nebacumab
Estradiol acetate may increase the thrombogenic activities of Nebacumab.
Alphacetylmethadol
Edrecolomab
Estradiol acetate may increase the thrombogenic activities of Edrecolomab.
Alphacetylmethadol
Bezlotoxumab
Estradiol acetate may increase the thrombogenic activities of Bezlotoxumab.
Alphacetylmethadol
Olokizumab
Estradiol acetate may increase the thrombogenic activities of Olokizumab.
Alphacetylmethadol
Tregalizumab
Estradiol acetate may increase the thrombogenic activities of Tregalizumab.
Alphacetylmethadol
Racotumomab
Estradiol acetate may increase the thrombogenic activities of Racotumomab.
Alphacetylmethadol
Namilumab
Estradiol acetate may increase the thrombogenic activities of Namilumab.
Alphacetylmethadol
Rovalpituzumab Tesirine
Estradiol acetate may increase the thrombogenic activities of Rovalpituzumab Tesirine.
Alphacetylmethadol
Robatumumab
Estradiol acetate may increase the thrombogenic activities of Robatumumab.
Alphacetylmethadol
Milatuzumab
Estradiol acetate may increase the thrombogenic activities of Milatuzumab.
Alphacetylmethadol
Bimekizumab
Estradiol acetate may increase the thrombogenic activities of Bimekizumab.
Alphacetylmethadol
Sacituzumab govitecan
Estradiol acetate may increase the thrombogenic activities of Sacituzumab govitecan.